Acadian Asset Management
BPMC

Acadian Asset Management’s Blueprint Medicines BPMC Stock Holding History

Acadian Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,934
Closed -$363K – 1679
2024
Q3 		$363K Buy
+3,934
New +$391K ﹤0.01% 1163
2021
Q3 		– Sell
-6,757
Closed -$595K – 1737
2021
Q2 		$595K Buy
6,757
+5,055
+297% +$463K ﹤0.01% 1088
2021
Q1 		$165K Sell
1,702
-4,313
-72% -$431K ﹤0.01% 1550
2020
Q4 		$675K Buy
+6,015
New +$634K ﹤0.01% 1124
2017
Q2 		– Sell
-41,227
Closed -$1.65M – 1445
2017
Q1 		$1.65M Buy
+41,227
New +$1.48M 0.01% 671

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Acadian Asset Management's BPMC Position: Q4 2024 in Review

Acadian Asset Management sold out of Blueprint Medicines (BPMC) in Q4 2024, closing a stake of 3,934 shares — an estimated $363K sold.

Acadian Asset Management first reported a position in BPMC in Q1 2017 and held it in 5 quarters. The position peaked at $1.65M in Q1 2017. 345 funds tracked by Wall St. Rank hold BPMC as of Q4 2024.

  • Acadian Asset Management reported no remaining Blueprint Medicines position as of Q4 2024 after selling out during the quarter.
  • Acadian Asset Management sold 3,934 Blueprint Medicines shares in Q4 2024, an estimated $363K.
  • Acadian Asset Management first reported a position in Blueprint Medicines in Q1 2017 and held it in 5 quarters.
  • Acadian Asset Management's Blueprint Medicines position peaked at $1.65M in Q1 2017.
  • 345 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2024.

Based on Acadian Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.